Second Sight Medical Products Inc. (EYES)
$24.86
$20.72
(500.53%)
As on 18-Jun-2026 15:58EDT
Market cap
$54 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-9 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
50.38
-
EV/EBITDA
0.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
13,136,400
10 Years Aggregate
CFO
$-202.86 Mln
EBITDA
$-224.18 Mln
Net Profit
$-239.74 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Second Sight Medical Products (EYES)
| -- | -- | -- | -- | -- | 3.4 | -12.0 |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Second Sight Medical Products (EYES)
| -12.8 | -68.5 | -16.2 | -53.4 | -3.0 | -66.6 | -42.6 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 | -3.4 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Second Sight Medical Products (EYES)
--
-
Acting Chief Exec. Officer
Mr. Scott Dunbar
-
Acting Chief Exec. Officer
Mr. Scott Dunbar
-
Headquarters
Sylmar, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Second Sight Medical Products (EYES)
What is the current share price of Second Sight Medical Products Inc (EYES) Today?
The share price of Second Sight Medical Products Inc (EYES) is $24.86 (NASDAQ) as of 18-Jun-2026 15:58 EDT. Second Sight Medical Products Inc (EYES) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Second Sight Medical Products Inc (EYES)?
Since, TTM earnings of Second Sight Medical Products Inc (EYES) is negative, P/E ratio is not available.
The P/B ratio of Second Sight Medical Products Inc (EYES) is 0.86 times as on 30-Aug-2022, a 75 discount to its peers’ median range of 3.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
What is the 52 Week High and Low of Second Sight Medical Products Inc (EYES)?
The 52-week high and low of Second Sight Medical Products Inc (EYES) are Rs 24.86 and Rs 24.70 as of 22-Jun-2026.
What is the market cap of Second Sight Medical Products Inc (EYES)?
Second Sight Medical Products Inc (EYES) has a market capitalisation of $ 54 Mln as on 30-Aug-2022. As per SEBI classification, it is a Small Cap company.
Should I invest in Second Sight Medical Products Inc (EYES)?
Before investing in Second Sight Medical Products Inc (EYES), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.